GEMINUS THERAPEUTICS
Geminus Therapeutics is developing best-in-class Artemisinin (ART714) for treating leukemia.
GEMINUS THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Address:
Baltimore, Maryland, United States
Country:
United States
Status:
Active
Total Funding:
150 K USD
Investors List
Maryland Innovation Initiative (MII)
Maryland Innovation Initiative (MII) investment in Grant - Geminus Therapeutics